Ki-67 is an important prognostic biomarker in breast cancer, especially for assessing tumor growth and guiding treatment decisions, such as reducing treatment intensity based on cancer aggressiveness [48], with higher levels associated with worse outcomes [49]. Here, MKI67 is linked to breast carcinoma.